Financhill
Sell
49

BEAM Quote, Financials, Valuation and Earnings

Last price:
$29.04
Seasonality move :
0.32%
Day range:
$26.74 - $29.20
52-week range:
$20.84 - $49.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.80x
P/B ratio:
3.04x
Volume:
2.7M
Avg. volume:
1.3M
1-year change:
5.1%
Market cap:
$2.4B
Revenue:
$377.7M
EPS (TTM):
-$1.76
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $18K $24K $51.8M $60.9M $377.7M
Revenue Growth (YoY) -- 33.33% 215916.67% 17.51% 520.01%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $54.6M $103.2M $387.1M $311.6M $437.4M
Selling, General & Admin $20.6M $29.6M $57.2M $87.8M $116.8M
Other Inc / (Exp) -$5.4M -$62.9M $21.8M $63M -$1.4M
Operating Expenses $75.2M $132.8M $444.3M $399.4M $554.2M
Operating Income -$75.2M -$132.8M -$392.5M -$338.5M -$176.5M
 
Net Interest Expenses -- -- $9K -- --
EBT. Incl. Unusual Items -$78.3M -$194.6M -$370.6M -$260.2M -$131.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $3.4M $1.4M
Net Income to Company -$78.3M -$194.6M -$370.6M -$289.1M -$132.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$78.3M -$194.6M -$370.6M -$289.1M -$132.5M
 
Basic EPS (Cont. Ops) -$2.01 -$4.19 -$5.77 -$4.13 -$1.72
Diluted EPS (Cont. Ops) -$2.01 -$4.19 -$5.77 -$4.13 -$1.72
Weighted Average Basic Share $45.3M $46.7M $64.2M $70M $77.2M
Weighted Average Diluted Share $45.3M $46.7M $64.2M $70M $77.2M
 
EBITDA -$71.7M -$128M -$385M -$324.3M -$156.5M
EBIT -$75.2M -$132.8M -$392.5M -$338.5M -$176.5M
 
Revenue (Reported) $18K $24K $51.8M $60.9M $377.7M
Operating Income (Reported) -$75.2M -$132.8M -$392.5M -$338.5M -$176.5M
Operating Income (Adjusted) -$75.2M -$132.8M -$392.5M -$338.5M -$176.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6K $763K $15.8M $17.2M $14.3M
Revenue Growth (YoY) -- 12616.67% 1970.64% 8.82% -17.01%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $29.8M $54.6M $85.3M $100.1M $94.3M
Selling, General & Admin $7.5M $15.8M $21.8M $25.4M $26.5M
Other Inc / (Exp) $2.7M $41.5M $4.7M -$519K -$2.3M
Operating Expenses $37.3M $70.4M $107.1M $125.5M $120.8M
Operating Income -$37.3M -$69.6M -$91.3M -$108.3M -$106.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$34.5M -$28.1M -$81.7M -$96.1M -$96.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $2.4M -- --
Net Income to Company -$34.5M -$28.1M -$109.6M -$96.1M -$96.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$34.5M -$28.1M -$109.6M -$96.1M -$96.7M
 
Basic EPS (Cont. Ops) -$0.69 -$0.42 -$1.56 -$1.22 -$1.17
Diluted EPS (Cont. Ops) -$0.69 -$0.42 -$1.56 -$1.22 -$1.17
Weighted Average Basic Share $50.1M $66.4M $70.3M $79M $82.4M
Weighted Average Diluted Share $50.1M $66.4M $70.3M $79M $82.4M
 
EBITDA -$36.1M -$67.9M -$87.8M -$103.1M -$101M
EBIT -$37.3M -$69.6M -$91.3M -$108.3M -$106.5M
 
Revenue (Reported) $6K $763K $15.8M $17.2M $14.3M
Operating Income (Reported) -$37.3M -$69.6M -$91.3M -$108.3M -$106.5M
Operating Income (Adjusted) -$37.3M -$69.6M -$91.3M -$108.3M -$106.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $24K $781K $92M $81.6M $349.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $90.9M $322.8M $322M $383.6M $406.2M
Selling, General & Admin $27.4M $47.8M $82.9M $96.2M $126.1M
Other Inc / (Exp) -$10M -$31.6M $17.7M $43.4M -$9.7M
Operating Expenses $118.4M $370.6M $404.9M $479.9M $532.3M
Operating Income -$118.3M -$369.8M -$313M -$398.3M -$182.7M
 
Net Interest Expenses -- $29K -- -- --
EBT. Incl. Unusual Items -$127M -$401.4M -$287.5M -$312.7M -$142.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$127M -$401.4M -$315.4M -$313.7M -$143.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$127M -$401.4M -$315.4M -$313.7M -$143.6M
 
Basic EPS (Cont. Ops) -$3.10 -$6.88 -$4.54 -$4.17 -$1.72
Diluted EPS (Cont. Ops) -$3.10 -$6.88 -$4.54 -$4.17 -$1.76
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$113.9M -$363.7M -$300.1M -$379.7M -$160.8M
EBIT -$118.3M -$369.8M -$313M -$398.3M -$182.7M
 
Revenue (Reported) $24K $781K $92M $81.6M $349.6M
Operating Income (Reported) -$118.3M -$369.8M -$313M -$398.3M -$182.7M
Operating Income (Adjusted) -$118.3M -$369.8M -$313M -$398.3M -$182.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $18K $775K $40.9M $61.5M $33.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $70.7M $290.3M $225.3M $297.3M $266.1M
Selling, General & Admin $21.3M $39.5M $65.1M $73.6M $82.9M
Other Inc / (Exp) -$8.2M $23.1M $19M -$593K -$9M
Operating Expenses $92M $329.8M $290.4M $370.9M $349M
Operating Income -$92M -$329M -$249.5M -$309.3M -$315.5M
 
Net Interest Expenses -- $73K -- -- --
EBT. Incl. Unusual Items -$99.1M -$305.9M -$222.8M -$275.3M -$286.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $2.4M -- $39K
Net Income to Company -$99.1M -$305.9M -$250.7M -$275.3M -$286.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$99.1M -$305.9M -$250.7M -$275.3M -$286.4M
 
Basic EPS (Cont. Ops) -$2.41 -$5.00 -$3.59 -$3.63 -$3.49
Diluted EPS (Cont. Ops) -$2.41 -$5.00 -$3.59 -$3.63 -$3.49
Weighted Average Basic Share $130.2M $188.8M $209.3M $227.6M $246.4M
Weighted Average Diluted Share $130.2M $188.8M $209.3M $227.6M $246.4M
 
EBITDA -$88.5M -$324.2M -$239.3M -$294.7M -$299M
EBIT -$92M -$329M -$249.5M -$309.3M -$315.5M
 
Revenue (Reported) $18K $775K $40.9M $61.5M $33.5M
Operating Income (Reported) -$92M -$329M -$249.5M -$309.3M -$315.5M
Operating Income (Adjusted) -$92M -$329M -$249.5M -$309.3M -$315.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $37.2M $162.2M $560M $232.8M $435.9M
Short Term Investments $54.6M $137.5M $405.7M $845.4M $754M
Accounts Receivable, Net -- -- $300M -- --
Inventory -- -- -- -- --
Prepaid Expenses $2.7M $8.7M -- -- --
Other Current Assets -- -- $7.4M $14.8M $21.2M
Total Current Assets $94.5M $308.3M $1.3B $1.1B $1.2B
 
Property Plant And Equipment $43.2M $125.4M $187M $234.1M $237.8M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $18.3M $18M $14.5M $14.7M $10.9M
Total Assets $156.1M $451.7M $1.5B $1.3B $1.5B
 
Accounts Payable $7.8M $6.3M $7.5M $9M $1.6M
Accrued Expenses $3.1M $6.6M $49M $18.5M $61.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $4.3M $4.2M $7.5M $10.4M $12.8M
Other Current Liabilities $10.3M $77.5M $51.5M $30.6M $39M
Total Current Liabilities $29.1M $102.3M $213.4M $223.6M $205.6M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $55.2M $206.1M $647.7M $608.2M $478.4M
 
Common Stock $302.1M $573K $684K $712K $816K
Other Common Equity Adj $16K -$9K -$50K -$2.4M $604K
Common Equity -$201.1M $245.6M $826.7M $733.5M $981.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $100.9M $245.6M $826.7M $733.5M $981.3M
 
Total Liabilities and Equity $156.1M $451.7M $1.5B $1.3B $1.5B
Cash and Short Terms $91.8M $299.7M $965.6M $1.1B $1.2B
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $137.9M $612M $156.5M $169M $230.2M
Short Term Investments $64.3M $321.4M $938M $846.4M $695.6M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $6.5M $8M $14.4M -- --
Other Current Assets -- -- -- $24.1M $19.8M
Total Current Assets $208.7M $941.4M $1.1B $1B $945.5M
 
Property Plant And Equipment $51.2M $174.7M $226.7M $239.7M $218.2M
Long-Term Investments -- $24.5M -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $18.4M $15.9M $14.6M $11.3M $7.6M
Total Assets $278.3M $1.2B $1.4B $1.3B $1.2B
 
Accounts Payable $6.6M $7.3M $7M $3.2M $3.8M
Accrued Expenses $13.8M $12M $13.5M $23.3M $35.5M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $4.3M $6.5M $9.8M $12M $12.9M
Other Current Liabilities $19.5M $57M $36.6M $14.8M $11M
Total Current Liabilities $47.5M $101.4M $238.9M $220.4M $166.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $78.2M $302.7M $635.8M $511.6M $380.1M
 
Common Stock $504K $677K $705K $794K $826K
Other Common Equity Adj $41K $19K -$4.7M -$2M $1.8M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $200.1M $853.8M $714.5M $778.9M $791.3M
 
Total Liabilities and Equity $278.3M $1.2B $1.4B $1.3B $1.2B
Cash and Short Terms $202.2M $933.4M $1.1B $1B $925.8M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$78.3M -$194.6M -$370.6M -$289.1M -$132.5M
Depreciation & Amoritzation $3.5M $4.7M $7.5M $14.1M $20M
Stock-Based Compensation $7M $15.4M $43.6M $84.3M $98.6M
Change in Accounts Receivable -- -- -$300M $300M -$146K
Change in Inventories -- -- -- -- --
Cash From Operations -$72M -$95.7M -$66.3M $22.5M -$149.2M
 
Capital Expenditures $12.5M $16.4M $46.8M $49M $33.7M
Cash Acquisitions -- -- $620K -- --
Cash From Investing -$66.7M -$100.1M -$294.1M -$461.3M $71.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $6.2M $3.3M -- -- --
Long-Term Debt Repaid -$464K -$1.6M -$2.1M -$2.3M -$2.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2.5M -$2.1M -$8.8M -$188K -$631K
Cash From Financing $41.3M $322.3M $756.1M $111.6M $276.4M
 
Beginning Cash (CF) $147.9M $50.6M $177M $572.7M $245.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$97.4M $126.5M $395.7M -$327.2M $199.1M
Ending Cash (CF) $50.6M $177M $572.7M $245.5M $444.6M
 
Levered Free Cash Flow -$84.5M -$112.1M -$113.1M -$26.4M -$182.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$34.5M -$28.1M -$109.6M -$96.1M -$96.7M
Depreciation & Amoritzation $1.2M $1.8M $3.5M $5.2M $5.5M
Stock-Based Compensation $3M $13M $22.2M $25.8M $29.6M
Change in Accounts Receivable -- $50M -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$21.2M $3M -$74.5M -$89.8M -$88.1M
 
Capital Expenditures $2.8M $5.8M $11.8M $7.9M $1.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing $35.2M $76.1M -$36.2M -$10.2M $24.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$411K -$530K -$579K -$400K -$201K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$52K -$209K -$25K -$384K --
Cash From Financing $94K $320.9M $1.6M $36.8M $1.3M
 
Beginning Cash (CF) $138.6M $226.9M $278.4M $241M $298.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $14.1M $400M -$109.1M -$63.2M -$62.2M
Ending Cash (CF) $152.7M $626.9M $169.3M $177.7M $236.8M
 
Levered Free Cash Flow -$24M -$2.8M -$86.3M -$97.7M -$89.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$127M -$401.4M -$315.4M -$313.7M -$143.6M
Depreciation & Amoritzation $4.5M $6.1M $12.8M $18.6M $21.8M
Stock-Based Compensation $10.6M $34.9M $77.3M $98.5M $113.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$89.2M -$92.4M $93.5M -$353.5M -$135.8M
 
Capital Expenditures $10.4M $41.6M $54.1M $38.4M $9.6M
Cash Acquisitions -- $620K -- -- --
Cash From Investing -$2.1M -$298.1M -$652.3M $87.2M $156.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $4M -- -- -- --
Long-Term Debt Repaid -$1.5M -$2M -$2.2M -$2.2M -$1.1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$3.2M -$9M -$262K -$685K --
Cash From Financing $193M $864.6M $101.1M $274.7M $38M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $101.6M $474.1M -$457.6M $8.5M $59M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$99.6M -$134M $39.5M -$391.9M -$145.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$99.1M -$305.9M -$250.7M -$275.3M -$286.4M
Depreciation & Amoritzation $3.5M $4.8M $10.2M $14.7M $16.5M
Stock-Based Compensation $8.6M $28.1M $61.8M $76M $90.4M
Change in Accounts Receivable -- -- $300M -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$71.4M -$68.1M $91.7M -$284.3M -$270.9M
 
Capital Expenditures $8.2M $33.4M $40.7M $30.1M $6M
Cash Acquisitions -- $620K -- -- --
Cash From Investing -$18.7M -$216.6M -$574.8M -$26.3M $58.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.6M -- -- -- --
Long-Term Debt Repaid -$1.2M -$1.6M -$1.7M -$1.6M -$485K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.7M -$8.7M -$134K -$631K --
Cash From Financing $192.3M $734.6M $79.6M $242.7M $4.3M
 
Beginning Cash (CF) $328.6M $515.9M $1.2B $746.1M $1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $102.2M $449.9M -$403.5M -$67.8M -$207.9M
Ending Cash (CF) $430.8M $965.8M $757.2M $678.3M $830M
 
Levered Free Cash Flow -$79.7M -$101.5M $51M -$314.4M -$276.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock